National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 53 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 53 of 2009

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 4 June 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — conditions

1              Commencement  

This instrument commences on 1 July 2009.

2              Amendment of PB 119 of 2008

Schedule 1 amends PB 119 of 2008.

Schedule 1            Amendments

[1]     Schedule 4, after item dealing with Mesalazine

insert in the columns in the order indicated:

Metformin Tablets (extended release) containing metformin hydrochloride 500 mg, 120

[2]     Schedule 4, after item dealing with Mometasone

insert in the columns in the order indicated:

Mupirocin Nasal ointment 20 mg (as calcium) per g, 3 g

[3]     Schedule 4, item dealing with Oestradiol and Oestradiol with Norethisterone

omit from the column headed “Form”:

Pack containing 12 tablets oestradiol 2 mg, 10 tablets oestradiol 2 mg with norethisterone acetate 1 mg and 6 tablets oestradiol 1 mg

[4]     Schedule 4, item dealing with Oestradiol with Norethisterone

omit from the column headed “Form”:

Tablets containing 1 mg oestradiol (as hemihydrate) with 500 micrograms norethisterone acetate, 28

Tablets containing 2 mg oestradiol (as hemihydrate) with 1 mg norethisterone acetate, 28